Señales en vivo de VRCA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 120624 min ago

@ $5.55

Emitido: 13 feb 2024 @ 10:00

Retorno: 31.83%

Señal anterior: feb 9 - 11:12

Señal anterior: Vender

Retorno: 2.31 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States...

Stats
Volumen de hoy	240 961
Volumen promedio	151 410
Capitalización de mercado	310.09M
EPS	$0 ( 2024-02-29 )
Próxima fecha de ganancias	( $-0.540 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.87
ATR14	$0.0160 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Hayes Christopher G.	Buy	40 000	Common Stock
2024-03-15	Hayes Christopher G.	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Goldenberg Gary	Buy	40 000	Common Stock
2024-03-15	Goldenberg Gary	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Kohler Terry	Buy	80 000	Employee Stock Option (right to buy)

INSIDER POWER
90.84
Last 98 transactions
Buy: 14 420 498 \| Sell: 288 608

Volumen Correlación

Largo: -0.14 (neutral)

Corto: 0.95 (very strong)

Signal:(67.326) Expect same movement, but be aware

Verrica Pharmaceuticals Correlación

10 Correlaciones Más Positivas
TGTX	0.959
IDCC	0.956
SLMBP	0.955
VBOCU	0.955
RAM	0.95
WKEY	0.95
OVLY	0.948
NCAC	0.947
MESA	0.946
GPACU	0.945

10 Correlaciones Más Negativas
CBNK	-0.945
CYTO	-0.939
GSMG	-0.938
GNTY	-0.936
BFRI	-0.936
FGBI	-0.936
GOOD	-0.934
AMNB	-0.93
CMLS	-0.929
ALHC	-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verrica Pharmaceuticals Correlación - Moneda/Commodity

-0.15
( neutral )

0.10
( neutral )

0.00
( neutral )

0.31
( neutral )

0.59
( weak )

0.23
( neutral )

Verrica Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$5.12M
Beneficio Bruto:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2023
Ingresos:	$5.12M
Beneficio Bruto:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2022
Ingresos:	$9.03M
Beneficio Bruto:	$8.31M (91.97 %)
EPS:	$-0.810

FY	2021
Ingresos:	$12.00M
Beneficio Bruto:	$12.00M (100.00 %)
EPS:	$-1.300

Financial Reports:

No articles found.

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Actualizaciones en tiempo real para Verrica Pharmaceuticals [VRCA]

Upcoming Earnings Alert